Krystal Biotech develops redosable gene therapies targeting rare skin diseases, with a late-stage clinical pipeline and ...

Krystal has released an improved Crispy Fish Slider in time for Lent, and is debuting Krush'd Sodas, a $1 upgrade that ...

Krystal Biotech KRYS reported fourth-quarter 2025 earnings per share (EPS) of $1.70, which surpassed the Zacks Consensus ...

Q VYJUVEK revenue and $730.3 million since U.S. launchFDA granted RMAT to KB707 for the treatment of advanced NSCLC and Fast ...

Krystal Nielson shared her traumatic experience giving birth to her and husband Miles Bowles' second baby, which included a ...

If you are wondering whether Krystal Biotech's share price still lines up with its underlying value, you are not alone. A closer look at its valuation can help frame that question more clearly. The ...

Analysts estimate that Krystal Biotech will report an earnings per share (EPS) of $1.61. Krystal Biotech bulls will hope to hear the company announce they've not only beaten that estimate, but also to ...

"In 2025, Krystal made meaningful progress on our mission to serve patients with dystrophic epidermolysis bullosa around the world, while continuing to build the global infrastructure required to ...

Krystal is leveraging a validated, redosable platform with high margins, profitability, and multiple blockbuster catalysts in ...

Open for decades, three Jacksonville-area Krystal restaurants have closed. One opened in the 1950s as the city's first ...